Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Bracing in Patellofemoral Osteoarthritis: A Clinical Trial
This study is currently recruiting participants.
Verified by Boston University, May 2008
Sponsored by: Boston University
Information provided by: Boston University
ClinicalTrials.gov Identifier: NCT00381563
  Purpose

The purpose of this study is as follows:

  1. To undertake a 18 week, double-blind, randomized crossover clinical trial in patients with patellofemoral osteoarthritis to determine whether provision of patellofemoral bracing leads to lower pain scores during the time of this research study procedure than during the use of a placebo research study procedure; and
  2. To perform a 6 month open label follow-up study to track use and effectiveness of the research study procedure.

We propose a double blind, randomized crossover trial to assess the effect of patellofemoral brace on knee pain among patients with patellofemoral osteoarthritis. The primary outcome will be knee pain as assessed by the VAS scale. A brace provides many features that may be therapeutic such as increased proprioceptive input, improved stability, and perhaps inhibition of knee flexion so as to avoid painful positions. Instead of these, it is our goal in this study to evaluate the therapeutic effect of a patellar brace- to test whether changing the tracking of the patella improves pain. Because of the other potential therapeutic effects of a brace listed above, we will also use a brace in the control research study period, one which provides the other benefits but not the biomechanical effects. The two research study procedure will be as follows: RESEARCH STUDY PROCEDURE A (CONTROL) a neutral brace without the donut (buttress) or realigning strap and RESEARCH STUDY PROCEDURE B (ACTIVE) the same patellofemoral brace with the donut and realigning strap.


Condition Intervention
Knee Osteoarthritis
Device: Knee brace

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Efficacy Study
Official Title: Bracing in Patellofemoral Osteoarthritis: A Clinical Trial

Further study details as provided by Boston University:

Primary Outcome Measures:
  • Change in pain on the VAS. [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • WOMAC, KOOS, Physical function, Pain with activity, Patient Assessment, SF36, Analgesic Use, Blinded knee, Physician Assessment, Functional performance, X-ray, Physical activity, PASE, and Knee strength [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: December 2006
Estimated Study Completion Date: July 2009
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental Device: Knee brace
PF realigning knee brace
2: Placebo Comparator Device: Knee brace
Non-aligning knee brace

Detailed Description:

Interventions that alter load distribution across the patellofemoral joint, such as patella taping may be helpful in alleviating symptoms. While patellar taping has been shown to be efficacious as an intervention for knee OA and patellofemoral OA more specifically, taping has not been widely adopted clinically and is not likely to be disseminated as a intervention in the future. Taping is complicated to administer, it is difficult to educate the patient about ongoing application, and there is no long-term study assessing its efficacy. Skin irritation occurs in a large proportion of subjects, and removal of the adhesive tape is uncomfortable. Bracing of the patellofemoral joint gets around the limitations of taping --- it is easy to put on and does not cause skin irritation. Given the pressing need for an effective intervention for PF OA, we propose to test whether provision of patellofemoral bracing was effective for relieving pain in symptomatic PF OA.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Persons with knee pain on most days
  • Either isolated PF OA or mixed PF and TF OA, based on x-ray

Exclusion Criteria:

  • Bed or chair bound subject or one who usually uses an ambulation aid to walk such as a cane, crutch, or walker or who gets around in a wheel chair.
  • Pain emanating more from back or hip than from knee as determined by screening questionnaire
  • Low pain score on VAS (<4 out of 10).
  • Planning to move from area within 10 months of study screening
  • Symptomatic comorbid disease (for example CHF or COPD) limits activities more than knee pain (per screening questionnaire)
  • Receiving corticosteroid injections in the month prior to starting the trial, or hyaluronan in the 6 month period before the trial. No other treatments will trigger exclusion, although for patients who have been on glucosamine +/or chondroitin +/or NSAID, we will require that they must have taken these treatments for at least 2 months prior to onset of trial and to commit to not start a new treatment throughout the trial.
  • Bilateral total knee replacements or plan for TKR in next 6 months for affected knee.
  • Morbidly obese (BMI>35) as brace fitting and prevention of slippage of the brace will be difficult.
  • Known other causes of arthritis including RA, SLE, gout, psoriatic arthritis, pseudogout.
  • Skin breakdown at the site where the brace will be applied.
  • Failure to pass run in test or brace falls down the leg during the run in.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00381563

Contacts
Contact: Kelly Lamb, BA 617.638.5492 klamb@bu.edu
Contact: Paula McCree, MA 617.638.4305 pmccree@bu.edu

Locations
United States, Massachusetts
Boston University, School of Medicine Not yet recruiting
Boston, Massachusetts, United States, 02118
Contact: Kelly Lamb, MA     617-638-5492     klamb@bu.edu    
Principal Investigator: David J Hunter, MD            
BU School of Medicine Recruiting
Boston, Massachusetts, United States, 02118
Contact: Kelly Lamb     617-638-5492     klamb@bu.edu    
Sponsors and Collaborators
Boston University
Investigators
Principal Investigator: David Hunter, MD BU, School of Medicine
  More Information

Responsible Party: BU School of Medicine ( David Hunter )
Study ID Numbers: 2 P60 AR047785-06
Study First Received: September 27, 2006
Last Updated: May 13, 2008
ClinicalTrials.gov Identifier: NCT00381563  
Health Authority: United States: Institutional Review Board

Keywords provided by Boston University:
Bracing
Patellofemoral
Knee osteoarthritis

Study placed in the following topic categories:
Osteoarthritis, Knee
Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on January 16, 2009